The World Health Organization has identified osteoporosis as a serious global health issue, second only to cardiovascular disease. In India alone, over 50 million people are affected by the disease. Osteoporosis is a disease that weakens the density and structure of bones, resulting in an increased risk of fractures. Treatments for osteoporosis usually involve a combination of medication, a healthy diet enriched with vitamins and minerals, and weight-bearing exercises that together can help to strengthen bones and prevent further loss of tissue. Although there is currently no cure for osteoporosis, researchers are constantly looking for new treatments to strengthen bones and protect them from breakdown.
Combining Therapies For Effective Treatment
Osteoporosis is caused by two factors – when too much bone tissue is destroyed and too little is created to replace the loss. One of the most common treatments for osteoporosis is a prescription for a group of drugs known as bisphosphonates. These are a group of drugs that work by reducing the activity of cells that destroy bone tissue. In contrast, research shows that osteoanabolic agents increase bone formation. Although yet to be approved for use, anabolic therapies could work well when combined with bisphosphonates because together they would address both factors that cause the disease.
Optimizing Absorption Of Vitamin K2
Several studies have shown that Vitamin K2 can help to improve bone health, and no further progress is being made to optimize the absorption of Vitamin K2 by the body. Vitamin K2 results in the production of osteocalcin, a protein hormone that can aid in the formation of bone. Unfortunately, it can be difficult to achieve the right concentration of Vitamin K2 in the body. To address this issue, researchers have found a way to regulate its absorption by using a carrier protein. This research could lead to Vitamin K2 providing effective treatment for osteoporosis.
Discovery Of New Bone Cells
Researchers in Australia have recently discovered a new type of bone cell that could help them develop further therapies for osteoporosis. Known as ectomorphs, the cells travel around the body in the blood and bone marrow, and are crucial to bone maintenance. They have been found to express genes that appear to have an impact on bone disease, and by understanding these cells and genes better, it may be possible to develop new therapies for the skeletal disease.
Osteoporosis is a prevalent disease affecting millions of people around the world. Ongoing research is leading to a much greater understanding of the disease, enabling the development of more therapies to treat its causes and consequences.